Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-19

Clinical Trial Update: The Effect of XueZhiKang on Fatigue:Comparing With Simvastatin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing XueZhiKang with Simvastatin for fatigue in dyslipidemia; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)
  • Xuezhikang

Snippet

Sponsor: Wenzhou Medical University | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED | Results posted: 2014-05-19